T0	Participants 41 54	breast cancer
T1	Participants 117 130	breast cancer
T2	Participants 219 280	long-term follow-up of the HIP breast cancer screening trial.
T3	Participants 324 343	breast cancer cases
T4	Participants 442 455	breast cancer
T5	Participants 672 685	breast cancer
T6	Participants 711 728	entire population